Cellesce

Cellesce has developed a patent-protected technology for the growing and expansion of organoids - a powerful new enabling technology, used in drug discovery

  • Stage Product In Development
  • Industry Biotechnology
  • Location Cardiff, United Kingdom
  • Currency GBP
  • Founded October 2013
  • Employees 4
  • Incorporation Type Other
  • Website cellesce.com

Company Summary

Cellesce is a biotechnology company that has developed a new (patent pending) bioprocessing technology for the growing and expansion of organoids. Big pharma, drug discovery companies and the developers of organoid banks are all looking for the means to industrialise the production of organoids. Cellesce has built and validated such a process and is now using this process to expand colorectal cancer organoids. Cellesce is seeking to raise £500k.

Team

  • Nicholas Duggan

  • Dr. Marianne Ellis
    Chief Technology Officer

    Marianne is an expert in the design of bioprocesses for cell therapies, particularly scalable bioreactors for cell expansion. She is the technical lead for Cellesce’s development projects. Marianne is currently Senior Lecturer in the Department of Chemical Engineering at the University of Bath, UK. Marianne has held a Royal Academy of Engineering/The Leverhulme Trust Senior Research Fellowship, and won an EPSRC ‘Rising Star’ award.

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free